FDA reopens comment period for neurological device reclassification

08/1/2010 | Clinica (subscription required)

The FDA has decided to reopen the period for accepting public feedback on a proposal to reclassify certain types of neurological and physical medicine devices from Class III, or high-risk, products to Class II, or medium-risk, devices. The agency has set a Sept. 7 deadline for public comments.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR